← All companies
ATHE
Alterity Therapeutics Limited
$4.46
-0.04 -0.96%
Key statistics
from XBRL data in SEC filingsMarket cap
$40.7B
Revenue (TTM)
—
Net income (TTM)
—
EPS (TTM)
—
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
—
Total assets
—
Gross margin
—
52-week range
$2.66 – $5.89
Recent SEC filings
40 most recentAnnual, quarterly & current reports
6-K
FORM 6-K
Jul 30, 2026
6-K
FORM 6-K
Jul 29, 2026
6-K
FORM 6-K
Jul 28, 2026
6-K
FORM 6-K
Jul 21, 2026
6-K
FORM 6-K
Jul 21, 2026
6-K
FORM 6-K
Jul 9, 2026
6-K
FORM 6-K
Jul 9, 2026
6-K
FORM 6-K
Jul 7, 2026
6-K
FORM 6-K
Jul 1, 2026
6-K
FORM 6-K
Jun 30, 2026
6-K
FORM 6-K
Jun 17, 2026
6-K
FORM 6-K
Jun 16, 2026
6-K
FORM 6-K
Jun 15, 2026
6-K
FORM 6-K
Jun 15, 2026
6-K
FORM 6-K
Jun 12, 2026
6-K
FORM 6-K
Jun 9, 2026
6-K
FORM 6-K
Jun 4, 2026
6-K
FORM 6-K
Jun 3, 2026
6-K
FORM 6-K
May 29, 2026
6-K
FORM 6-K
May 19, 2026
6-K
FORM 6-K
May 12, 2026
6-K
FORM 6-K
May 11, 2026
6-K
FORM 6-K
May 7, 2026
6-K
FORM 6-K
Apr 30, 2026
6-K
FORM 6-K
Apr 30, 2026
6-K
FORM 6-K
Apr 29, 2026
6-K
FORM 6-K
Apr 27, 2026
6-K
FORM 6-K
Apr 27, 2026
6-K
FORM 6-K
Apr 22, 2026
6-K
FORM 6-K
Apr 21, 2026
6-K
FORM 6-K
Apr 20, 2026
6-K
FORM 6-K
Apr 20, 2026
6-K
FORM 6-K
Apr 17, 2026
6-K
FORM 6-K
Apr 16, 2026
6-K
FORM 6-K
Apr 15, 2026
6-K
FORM 6-K
Apr 1, 2026
6-K
FORM 6-K
Mar 30, 2026
6-K
FORM 6-K
Mar 26, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Mar 19, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Mar 16, 2026